120 related articles for article (PubMed ID: 7812982)
21. Pseudouridine determination in blood serum as tumor marker.
Salvatore F; Russo T; Colonna A; Cimino L; Mazzacca G; Cimino F
Cancer Detect Prev; 1983; 6(6):531-6. PubMed ID: 6318996
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
25. [Behavior of serum sialic acid levels at various stages of neoplastic disease].
Adamo V; Altavilla G; Caristi N; Chillemi S; Giacobello T; Scalisi R; Palmara D
Minerva Med; 1985 Nov; 76(43):2067-70. PubMed ID: 4069416
[TBL] [Abstract][Full Text] [Related]
26. High levels of S-100a0 (alpha alpha) protein in tumor tissues and in sera of patients with renal cell carcinoma.
Kato K; Haimoto H; Ariyoshi Y; Horisawa M; Washida H; Kimura S
Jpn J Cancer Res; 1985 Sep; 76(9):856-62. PubMed ID: 3932285
[TBL] [Abstract][Full Text] [Related]
27. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
28. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
29. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
[TBL] [Abstract][Full Text] [Related]
31. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
32. Serum osteoprotegerin levels in healthy controls and cancer patients.
Lipton A; Ali SM; Leitzel K; Chinchilli V; Witters L; Engle L; Holloway D; Bekker P; Dunstan CR
Clin Cancer Res; 2002 Jul; 8(7):2306-10. PubMed ID: 12114435
[TBL] [Abstract][Full Text] [Related]
33. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
Eto M; Kodama S; Uemura N; Suzuki M
Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of fibronectin and a fibronectin-like DNA-binding protein in patients with various diseases.
Todd HD; Coffee MS; Waalkes TP; Abeloff MD; Parsons RG
J Natl Cancer Inst; 1980 Nov; 65(5):901-4. PubMed ID: 6253707
[TBL] [Abstract][Full Text] [Related]
35. Two-dimensional acrylamide gel electrophoresis of cancer-patient serum proteins.
Wright GL
Ann Clin Lab Sci; 1974; 4(4):281-93. PubMed ID: 4376659
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to MuMTV proteins in the sera of mammary carcinoma patients' healthy daughters.
Litvinov S; Kryukova I; Hint E; Purde M
Arch Geschwulstforsch; 1986; 56(6):407-12. PubMed ID: 3030219
[TBL] [Abstract][Full Text] [Related]
37. Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites.
Honegger H; Anderson N; Hewitt LA; Tullis JL
Thromb Haemost; 1981 Aug; 46(2):500-3. PubMed ID: 7302888
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of a serum immunosuppressive (IS) substance in various diseases].
Mannami T; Fuchimoto S; Amamiya S; Morioka S; Tanaka S; Tanaka N; Konaga E; Orita K
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2104-12. PubMed ID: 6191693
[TBL] [Abstract][Full Text] [Related]
39. [Determination of beta2-microglobulin in breast, lung, colorectal and ENT carcinoma (author's transl)].
Viot G; Leca M; Moll JL; de Salvador F; Namer M; Demard F; Krebs BP
Pathol Biol (Paris); 1978 Sep; 26(6):351-2. PubMed ID: 83582
[TBL] [Abstract][Full Text] [Related]
40. Serum transcobalamin II levels in breast carcinoma patients.
Rachmilewitz B; Sulkes A; Rachmilewitz M; Fuks Z
Isr J Med Sci; 1981; 17(9-10):874-8. PubMed ID: 7309476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
